Search
Sanara Medtech Inc
SMTIAdd to Watchlist
24.840USD
+0.570+2.35%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
227.66MMarket Cap
LossP/E TTM
More Details of Sanara Medtech Inc Company
Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.
Sanara Medtech Inc Info
Ticker SymbolSMTI
Company nameSanara Medtech Inc
IPO dateApr 07, 1994
CEOMuppalla (Suresh V)
Number of employees141
Security typeOrdinary Share
Fiscal year-endApr 07
Address1200 Summit Avenue
CityFORT WORTH
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code76102
Phone18175292300
Websitehttps://sanaramedtech.com/
Ticker SymbolSMTI
IPO dateApr 07, 1994
CEOMuppalla (Suresh V)
Company Executives of Sanara Medtech Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
9.32K
+47.02%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Robert A. (Bob) DeSutter
Mr. Robert A. (Bob) DeSutter
Independent Director
Independent Director
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%
FAQs
Who are the top five shareholders of Sanara Medtech Inc?
The top five shareholders of Sanara Medtech Inc are: Mr. Seth D. Yon
How many institutions hold shares of Sanara Medtech Inc (SMTI)?
As of 2026Q1, 131 institutions hold shares of Sanara Medtech Inc, with a combined market value of approximately 1.42M, accounting for 15.50% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -599767.00.
What is the biggest source of revenue for Sanara Medtech Inc?
In 2026Q1, the Soft tissue repair products business generated the highest revenue for Sanara Medtech Inc, amounting to 91.35M and accounting for 88.59% of total revenue.